67 results
SC 14D9
CELL
Bruker Cellular Analysis, Inc.
31 Aug 23
Tender offer solicitation
4:47pm
, including statements concerning Parent’s and the Company’s plans, objectives, goals, beliefs, strategy and strategic objectives, future events … ,” “continue,” “could,” “estimate,” “expect,” “goal,” “intend,” “may,” “plan,” “potential” “predict,” “project,” “seek,” “should,” “strategy,” “target
SC TO-T
EX-99
CELL
Bruker Cellular Analysis, Inc.
31 Aug 23
Third party tender offer statement
4:11pm
in the investment strategy and infrastructure of academic as well as government research markets. Further, Dr. Friend has substantial management … than 30 years of international business and corporate strategy experience and brings to the Board a valuable understanding of the pharmaceutical
SC TO-T
EX-99
CELL
Bruker Cellular Analysis, Inc.
31 Aug 23
Third party tender offer statement
4:11pm
) to be competitively sensitive (e.g., detailed information regarding pricing, including pricing strategy, sales or promotional plans, strategic plans
SC14D9C
EX-99.1
CELL
Bruker Cellular Analysis, Inc.
18 Aug 23
Written communication relating to third party tender offer
5:21pm
opportunities for employees. Bruker considers PhenomeX as a pivotal investment in its strategy, Project Accelerate 2.0, which is focused … , including statements concerning the Company’s plans, objectives, goals, beliefs, strategy and strategic objectives, future events, business conditions
SC14D9C
EX-99.2
CELL
Bruker Cellular Analysis, Inc.
18 Aug 23
Written communication relating to third party tender offer
5:21pm
, other than statements of historical facts, including statements concerning the Company’s plans, objectives, goals, beliefs, strategy and strategic … ,” “strategy,” “target,” or “will” or the negatives of these terms or variations of them or similar terminology. Readers are cautioned that any
SC14D9C
usml8sboqg7r oz10
18 Aug 23
Written communication relating to third party tender offer
5:21pm
SC14D9C
xhsr964v87tx1o
17 Aug 23
Written communication relating to third party tender offer
5:28pm
SC14D9C
EX-99.1
7e56hsee 50sycp
17 Aug 23
Written communication relating to third party tender offer
5:28pm
8-K
rukcs nfkful7twnl
17 Aug 23
Entry into a Material Definitive Agreement
5:27pm
8-K
EX-2.1
j9g5hcd e9b1rajbyz
17 Aug 23
Entry into a Material Definitive Agreement
5:27pm
SC TO-C
lssgag
17 Aug 23
Information about tender offer
4:05pm
SC TO-C
EX-99.1
vwhab4uhqx9c
17 Aug 23
Information about tender offer
4:05pm
SC14D9C
icgqofbziws
17 Aug 23
Written communication relating to third party tender offer
9:10am
8-K
7lfbqv8vzyv vs
17 Aug 23
Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
9:09am
8-K
EX-99.1
l7fcfw
17 Aug 23
Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
9:09am
8-K
EX-99.1
93dxya uhi
14 Aug 23
PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.1
vp95pnp4 hopq2f7l
10 Apr 23
PhenomeX Appoints Peter Silvester to PhenomeX Board of Directors
9:43am